FluoGuide A/S (STO:FLUO)
29.50
0.00 (0.00%)
Nov 20, 2026, 5:25 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 482.3 million as of November 20, 2026. It is the 29,905th most valuable company in the world and the 392nd biggest in Sweden. Its market cap has decreased by 24.74% in one year.
Market Cap
482.30M
Enterprise Value
449.24M
Revenue
404.33K
Global Rank
Country Rank
#392 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 482.30M, an increase of 1,105.08%. That is a compound annual growth rate of 39.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 482.30M | -13.99% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 934.92M |
| AlzeCure Pharma AB | 783.26M |
| SynAct Pharma AB | 727.98M |
| Medivir AB | 651.64M |
| Oncopeptides AB | 648.27M |
| Xspray Pharma AB | 482.70M |
| Sprint Bioscience AB | 388.30M |
| Corline Biomedical AB | 365.86M |